
Opinion|Videos|February 7, 2025
Therapy Sequencing in CLL
Panelists discuss how therapy sequencing is approached for patients with chronic lymphocytic leukemia (CLL), with a focus on how prior therapy exposure influences the choice of subsequent treatments.
Advertisement
Episodes in this series

- How do you sequence therapies for patients with CLL, and how does prior therapy exposure influence your subsequent choice of treatments?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Integrated Care for Chronic Conditions: A Randomized Care Management Trial
2
It’s Time to Reimagine Reimbursement for CAR T-Cell Therapy
3
What ACA Subsidy Expiration Means for Coverage Costs, Employer Strategy, and ICHRAs: Q&A With Ben Light
4
Fee-for-Service Models Linked to Higher Odds of Low-Value Surgical Procedures
5
















































